Literature DB >> 31675246

Immortal Time Bias Question in the Association Between Toxicity and Outcome of Immune Checkpoint Inhibitors.

Filippo G Dall'Olio1, Vincenzo Di Nunno1, Francesco Massari1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31675246     DOI： 10.1200/JCO.19.01728

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab.

Authors:  Kosuke Mizutani; Toshiki Ito; Kiyoshi Takahara; Ryosuke Ando; Takuma Ishihara; Takahiro Yasui; Ryoichi Shiroki; Hideaki Miyake; Takuya Koie
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

2.  Immortal Time Bias in Comparing Late vs Early Intubation in Patients With Coronavirus Disease 2019.

Authors:  Li Hong
Journal:  Chest       Date:  2021-04-06       Impact factor: 9.410

Review 3.  The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer.

Authors:  Philip Bredin; Jarushka Naidoo
Journal:  Cancer Metastasis Rev       Date:  2022-07-25       Impact factor: 9.237

4.  Bilateral Posterior Uveitis and Retinal Detachment During Immunotherapy: A Case Report and Literature Review.

Authors:  Ling Peng; Qi-Qi Mao; Bo Jiang; Jin Zhang; Yi-Lei Zhao; Xiao-Dong Teng; Jin-Song Yang; Yang Xia; Shi-Qing Chen; Justin Stebbing; Hai Jiang
Journal:  Front Oncol       Date:  2020-11-09       Impact factor: 6.244

Review 5.  Immune-related adverse events and the balancing act of immunotherapy.

Authors:  Michael Conroy; Jarushka Naidoo
Journal:  Nat Commun       Date:  2022-01-19       Impact factor: 14.919

6.  Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer.

Authors:  Lea Daniello; Mariam Elshiaty; Farastuk Bozorgmehr; Jonas Kuon; Daniel Kazdal; Hannah Schindler; Rajiv Shah; Anna-Lena Volckmar; Fabienne Lusky; Leonore Diekmann; Stephan Liersch; Martin Faehling; Thomas Muley; Mark Kriegsmann; Karolina Benesova; Albrecht Stenzinger; Michael Thomas; Petros Christopoulos
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.